Ashfaq Shuaib
Ashfaq Shuaib is an expert in Neurology at University of Alberta (Canada). As of October 2026, ScienceLeadR ranks Ashfaq Shuaib in the top 1% of experts worldwide for Brain Ischemia, Cerebrovascular Disorders and Brain Infarction. Ashfaq Shuaib has authored 722 publications, the most recent in 2026, and is an investigator in 46 clinical trials, 1 of them ongoing. SLR score: 2,625 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Cardiology - Medical Imaging - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Dr. Ashfaq Shuaib received his undergraduate medical education at Khyber Medical College in Pakistan, obtaining his MBBS degree in 1980.Thereafter, he did post-graduate training in Internal Medicine and Neurology at the University of Calgary between 1983 and 1988, followed by specialized training in cerebrovascular research at the University of Western Ontario and Duke University Medical School in Durham, North Carolina.
He returned to Canada as an assistant professor in Medicine and Neurology at the University of Saskatchewan in 1989 and rose rapidly through the academic ranks to be appointed full professor in July 1995.In addition, he held the position of program director in the Division of Neurology between 1990 and 1995, supervised numerous research fellows and graduate students and was the Director of the Saskatchewan Stroke Research Centre and Director of the WHO Centre.
He joined the University of Alberta as Professor of Medicine and Director of the Division of Neurology September 1, 1997 - July 2007 and Director of the Stroke Program 1997 - 2024. His major interest is in the understanding of the basic mechanisms of cerebral ischemia and clinical trials in cerebrovascular diseases. He has published over 670 articles in peer-reviewed journals (H-index 85 CI 102,225) and his research is funded by the CIHR, Heart and Stroke Foundation of Alberta, NIH, Alberta Innovates and the industry. He is the co-chair of the NIH funded conference on collaterals and the stroke section of CONy. He has served on the editorial board of the Stroke, Neurohospitalist, J of Neuroscience (Pakistan), Post-Graduate Journal (Pakistan), Heart Org. and Associate Editor of Frontiers in Neuroscience and Faculty F-1000.
Organizations
Career arc: 1987 - 2026
Number : 722
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Bleeding With Asundexian Versus Placebo in Patients With Noncardioembolic Ischemic Stroke or High-Risk TIA: OCEANIC-STROKE Randomized Trial. PMID 42866879 — hemorrhage, ischemic stroke, stroke, cardiovascular system, therapeutics, blood circulation | Circulation Top journal | 2026 | 0 |
| Monitoring of Remote Ischemic Conditioning with a Tissue Reflectance Sensor: A Randomized Control Trial. PMID 42858287 — ischemic stroke, stroke, cerebrovascular disorders, conditioning, psychological, tissues | Cerebrovasc Dis | 2026 | 0 |
| Efficacy and safety of milrinone infusion in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. PMID 42780004 — mortality, safety, hemorrhage, incidence, subarachnoid hemorrhage, milrinone, drug-related side effects and adverse reactions, therapeutics, ischemia | Front Neurol | 2026 | 0 |
| A Comparison of Machine Learning Models for ICH Prognostication: An Analysis of ATACH-2 and Qatar Stroke Database. PMID 42768786 — mortality, cerebral hemorrhage, stroke, machine learning, learning, nervous system diseases | Can J Neurol Sci | 2026 | 0 |
| Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial. PMID 42558067 — brain injuries, cerebral hemorrhage, hemorrhage, colchicine, neuroimaging, pharmaceutical preparations, cerebrovascular circulation, cerebrovascular disorders, medication adherence, risk factors, random allocation | Stroke | 2026 | 0 |
Clinical Studies 46
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 7
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) NCT05065216 — injections, kallikreins, safety, ischemic stroke, stroke, solutions, therapeutics, tissues, tissue kallikreins, ischemia | Phase 2/Phase 3 | Recruiting | 2021 |
LeadR Networks
Main global connection map